Statements (54)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:computer
|
gptkbp:advocates_for |
gptkb:ME_Association
gptkb:Massachusetts_ME/_CFS_&_FM_Association gptkb:Solve_ME/_CFS_Initiative ME/ CFS Support Group |
gptkbp:affects |
gptkb:Person
adults |
gptkbp:associated_with |
pain
neurological symptoms dysautonomia orthostatic intolerance |
gptkbp:caused_by |
immune system dysfunction
viral infections |
gptkbp:first_described_by |
1930s
|
gptkbp:healthcare |
gptkb:historical_event
autoimmune diseases anxiety disorders fibromyalgia irritable bowel syndrome |
https://www.w3.org/2000/01/rdf-schema#label |
Myalgic Encephalomyelitis
|
gptkbp:impact |
quality of life
social interactions daily activities work ability |
gptkbp:is_known_for |
gptkb:computer
|
gptkbp:is_popular_in |
0.1% to 0.5% of the population
|
gptkbp:public_awareness |
gptkb:ME_Awareness_Day
# ME Action |
gptkbp:public_perception |
chronic illness
misunderstood condition invisible illness stigmatized illness |
gptkbp:receives_funding_from |
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:Research_Institute private foundations limited research funding |
gptkbp:research |
ongoing
|
gptkbp:social_responsibility |
gptkb:Fukuda_criteria
clinical evaluation Canadian Consensus Criteria Institute of Medicine criteria |
gptkbp:symptoms |
fatigue
sleep disturbances cognitive dysfunction post-exertional malaise |
gptkbp:treatment |
cognitive behavioral therapy
biomedical research nutritional supplements symptomatic management graded exercise therapy alternative therapies pharmaceutical interventions |
gptkbp:bfsParent |
gptkb:computer
|
gptkbp:bfsLayer |
3
|